Literature DB >> 12625458

Type II glucocorticoid receptor immunoreactivity in the mossy cells of the rat and the mouse hippocampus.

Anisha Patel1, Karen Bulloch.   

Abstract

Hippocampal principal neurons, granule and pyramidal cells, are known to express type II glucocorticoid receptors (GR) and it is believed that glucocorticoids (GC) mediate at least some of their effects through GR. Under conditions of severe stress and trauma, these principal cells are vulnerable to damage and this mechanism may be exacerbated by GR. The mossy cell, an excitatory dentate gyrus neuron, is also damaged following trauma, with over 50% reported loss in rats after kainate-induced seizures. However, it has not been determined if GC play any role in protecting or exacerbating damage to this important hippocampal cell type. In the present study, we have undertaken an evaluation of the presence of GR in mossy cells of the rat and mouse utilizing an immunocytochemical double-labeling technique. To identify mossy cells in the rat, we utilized an antibody to the glutamate receptor subunit 2/3 (GluR2/3). In addition to GluR2/3 antibodies, in the mouse, an antibody to the calcium-binding protein, calretinin (CR), to identify mossy cells was also employed. Our results show that GR immunoreactivity (IR) was colocalized with GluR2/3-IR in approximately 90% of the rat and the mouse mossy cells. In addition, GR-IR was identified in the CR-IR mossy cells in the mouse hippocampus, whereas the CR-IR interneurons of rat and mouse were negative for GR-IR. The presence of GR on mossy cells may indicate the ability of GC to mediate cellular activity of these cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12625458     DOI: 10.1002/hipo.10045

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  9 in total

Review 1.  Sleep, dreams, and memory consolidation: the role of the stress hormone cortisol.

Authors:  Jessica D Payne; Lynn Nadel
Journal:  Learn Mem       Date:  2004 Nov-Dec       Impact factor: 2.460

2.  A novel therapeutic approach for treatment of catamenial epilepsy.

Authors:  Suchitra Joshi; Huayu Sun; Karthik Rajasekaran; John Williamson; Edward Perez-Reyes; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2017-12-21       Impact factor: 5.996

Review 3.  The enigmatic mossy cell of the dentate gyrus.

Authors:  Helen E Scharfman
Journal:  Nat Rev Neurosci       Date:  2016-07-28       Impact factor: 34.870

4.  Differential subcellular localization of the glucocorticoid receptor in distinct neural stem and progenitor populations of the mouse telencephalon in vivo.

Authors:  Maria A Tsiarli; A Paula Monaghan; Donald B Defranco
Journal:  Brain Res       Date:  2013-06-07       Impact factor: 3.252

5.  Novelty and Novel Objects Increase c-Fos Immunoreactivity in Mossy Cells in the Mouse Dentate Gyrus.

Authors:  Hannah L Bernstein; Yi-Ling Lu; Justin J Botterill; Helen E Scharfman
Journal:  Neural Plast       Date:  2019-08-27       Impact factor: 3.599

6.  Impact of stress on inhibitory neuronal circuits, our tribute to Bruce McEwen.

Authors:  Marta Perez-Rando; Hector Carceller; Esther Castillo-Gomez; Clara Bueno-Fernandez; Clara García-Mompó; Javier Gilabert-Juan; Ramón Guirado; Ana Paula Pesarico; Juan Nacher
Journal:  Neurobiol Stress       Date:  2022-05-13

7.  Hilar mossy cells of the dentate gyrus: a historical perspective.

Authors:  Helen E Scharfman; Catherine E Myers
Journal:  Front Neural Circuits       Date:  2013-01-09       Impact factor: 3.492

8.  DNA methylation mediates persistent epileptiform activity in vitro and in vivo.

Authors:  Ziv M Machnes; Tony C T Huang; Philip K Y Chang; Raminder Gill; Nicholas Reist; Gabriella Dezsi; Ezgi Ozturk; Francois Charron; Terence J O'Brien; Nigel C Jones; R Anne McKinney; Moshe Szyf
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

9.  RU486 Mitigates Hippocampal Pathology Following Status Epilepticus.

Authors:  Aynara C Wulsin; James P Herman; Steve C Danzer
Journal:  Front Neurol       Date:  2016-11-28       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.